Proposed Investment in Kromek Pharma plc

RNS Number : 9734O

Intuitive Investments Group plc

12 February 2021

 

12 February 2021

Intuitive Investments Group plc

Proposed Investment in  Kromek Pharma plc

Intuitive Investments Group plc (AIM: IIG) ("IIG"), a closed-end investment company focussed on the life sciences sector, announces an investment of £249,975 to acquire 1.66 million ordinary shares of Kromek Group plc (AIM:KMK) ("Kromek") at a price of 15 pence per share (the "Investment"). The Investment is part of the fundraising announced by Kromek on 12 February 2021. The Investment is conditional upon, amongst other things, the resolutions being passed at Kromek's forthcoming general meeting on 1 March 2021.

Kromek Group plc is a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets.

The Investment in Kromek is the Company's fifth investment following its IPO in mid-December 2020.

For further information, please contact:

Intuitive Investments Group plc
David Evans	Via Walbrook PR
Strand Hanson Limited - Nominated Adviser	[phone]
James Harris / James Dance / James Bellman
Turner Pope Investments (TPI) Ltd - Broker	[phone]
Andrew Thacker / Zoe Alexander
Walbrook PR Limited - Media & Investor Relations	[phone] or [e-mail]
Paul McManus	[phone]

About Intuitive Investments Group plc

  The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

 

END

 

 

MSCTTMBTMTJBBPB